Clinical Trials Browser

Recruiting × Down Syndrome × Daunorubicin × Clear all

NCT07232134 2025-11-20

AML-DS-2025

Phase 3 Recruiting

Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute